{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-032951","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2026-08-14T12:30:52+00:00","discovered_at":"2026-08-14T12:35:12.426910+00:00","generated_at":"2026-08-14T12:35:18.708139+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Crinetics-Vertex merger clears HSR and key antitrust hurdles; close expected early Sept","bullets":["HSR waiting period expired Aug 12, 2026 at 12:45 p.m. ET.","Antitrust approvals received in Austria, Germany, Australia; Australia waiting period expires Aug 27, 2026.","Shareholder vote scheduled for Aug 28, 2026; merger expected to close early September 2026.","Deal projected to support >$5B annual revenue and be accretive to non-GAAP operating income in 2029."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-032951","json":"https://secwatch.observer/filing/0001140361-26-032951.json","markdown":"https://secwatch.observer/filing/0001140361-26-032951.md","text":"https://secwatch.observer/filing/0001140361-26-032951.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126032951/0001140361-26-032951-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126032951/ef20080199_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T12:35:18.708139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}